DE3751128T2 - Rekombinante gereinigte Protease, Nexin. - Google Patents

Rekombinante gereinigte Protease, Nexin.

Info

Publication number
DE3751128T2
DE3751128T2 DE3751128T DE3751128T DE3751128T2 DE 3751128 T2 DE3751128 T2 DE 3751128T2 DE 3751128 T DE3751128 T DE 3751128T DE 3751128 T DE3751128 T DE 3751128T DE 3751128 T2 DE3751128 T2 DE 3751128T2
Authority
DE
Germany
Prior art keywords
nexin
recombinant purified
purified protease
cloned
diagnostic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE3751128T
Other languages
English (en)
Other versions
DE3751128D1 (de
Inventor
Michael P Mcgrogan
Randy W Scott
Joffrey B Baker
Christian C Simonsen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Incyte Corp
Original Assignee
University of Kansas
Incyte Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Kansas, Incyte Pharmaceuticals Inc filed Critical University of Kansas
Publication of DE3751128D1 publication Critical patent/DE3751128D1/de
Application granted granted Critical
Publication of DE3751128T2 publication Critical patent/DE3751128T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
DE3751128T 1986-06-03 1987-06-03 Rekombinante gereinigte Protease, Nexin. Expired - Fee Related DE3751128T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US87023286A 1986-06-03 1986-06-03
US87150186A 1986-06-06 1986-06-06
US07/025,450 US5278049A (en) 1986-06-03 1987-03-13 Recombinant molecule encoding human protease nexin

Publications (2)

Publication Number Publication Date
DE3751128D1 DE3751128D1 (de) 1995-04-13
DE3751128T2 true DE3751128T2 (de) 1995-07-20

Family

ID=27362550

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3751128T Expired - Fee Related DE3751128T2 (de) 1986-06-03 1987-06-03 Rekombinante gereinigte Protease, Nexin.

Country Status (7)

Country Link
US (2) US5278049A (de)
EP (1) EP0251505B1 (de)
AT (1) ATE119574T1 (de)
AU (1) AU625492B2 (de)
CA (1) CA1339447C (de)
DE (1) DE3751128T2 (de)
ES (1) ES2072250T3 (de)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8602626D0 (en) * 1986-02-04 1986-03-12 Ciba Geigy Ag Neurite-promoting factor
US5206017A (en) * 1986-06-03 1993-04-27 Incyte Pharmaceuticals, Inc. Use of protease nexin-I as an antiinflammatory
US5134076A (en) * 1988-09-27 1992-07-28 The Regents Of The University Of California Monoclonal antibodies specific for protease nexin-1 and puriciation of protease nexin-1 using monoclonal antibodies
WO1991016628A1 (en) * 1990-04-24 1991-10-31 The Regents Of The University Of California Purification, detection and methods of use of protease nexin-2
US5187089A (en) * 1990-06-21 1993-02-16 Incyte Pharmaceuticals, Inc. Protease nexin-i variants which inhibit elastase
US5766897A (en) * 1990-06-21 1998-06-16 Incyte Pharmaceuticals, Inc. Cysteine-pegylated proteins
US20070259806A1 (en) * 1996-10-11 2007-11-08 Human Genome Sciences, Inc. Brain-Associated Inhibitor of Tissue-Type Plasminogen Activator
US7235529B2 (en) * 1996-10-11 2007-06-26 Human Genome Sciences, Inc. Brain-associated inhibitor of tissue-type plasminogen activator
US6008020A (en) 1996-10-11 1999-12-28 Human Genome Sciences Brain-associated inhibitor of tissue-type plasminogen activator
US7179892B2 (en) * 2000-12-06 2007-02-20 Neuralab Limited Humanized antibodies that recognize beta amyloid peptide
US6761888B1 (en) * 2000-05-26 2004-07-13 Neuralab Limited Passive immunization treatment of Alzheimer's disease
TWI239847B (en) * 1997-12-02 2005-09-21 Elan Pharm Inc N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
US20080050367A1 (en) * 1998-04-07 2008-02-28 Guriq Basi Humanized antibodies that recognize beta amyloid peptide
US6913745B1 (en) 1997-12-02 2005-07-05 Neuralab Limited Passive immunization of Alzheimer's disease
US7964192B1 (en) 1997-12-02 2011-06-21 Janssen Alzheimer Immunotherapy Prevention and treatment of amyloidgenic disease
US7588766B1 (en) 2000-05-26 2009-09-15 Elan Pharma International Limited Treatment of amyloidogenic disease
US7790856B2 (en) * 1998-04-07 2010-09-07 Janssen Alzheimer Immunotherapy Humanized antibodies that recognize beta amyloid peptide
US6787523B1 (en) * 1997-12-02 2004-09-07 Neuralab Limited Prevention and treatment of amyloidogenic disease
US20050059802A1 (en) * 1998-04-07 2005-03-17 Neuralab Ltd Prevention and treatment of amyloidogenic disease
WO2000053793A1 (en) * 1999-03-10 2000-09-14 Human Genome Sciences, Inc. Brain-associated inhibitor of tissue-type plasminogen activator
CN101670105B (zh) * 2000-02-24 2014-08-06 华盛顿大学 螯合淀粉样蛋白β肽的人源化抗体
US6673623B1 (en) 2000-09-12 2004-01-06 Novocure, Inc. Methods and compositions that control lipid production
US7700751B2 (en) 2000-12-06 2010-04-20 Janssen Alzheimer Immunotherapy Humanized antibodies that recognize β-amyloid peptide
PE20020574A1 (es) * 2000-12-06 2002-07-02 Wyeth Corp Anticuerpos humanizados que reconocen el peptido amiloideo beta
DK1944040T3 (da) * 2001-08-17 2012-10-29 Univ Washington Analysefremgangsmåde for Alzheimers sygdom
MY139983A (en) * 2002-03-12 2009-11-30 Janssen Alzheimer Immunotherap Humanized antibodies that recognize beta amyloid peptide
US7666981B1 (en) * 2002-05-10 2010-02-23 University Of Central Florida Research Foundation, Inc. Inhibitors of prostasin
WO2004069182A2 (en) * 2003-02-01 2004-08-19 Neuralab Limited Active immunization to generate antibodies to soluble a-beta
WO2004071408A2 (en) * 2003-02-10 2004-08-26 Applied Molecular Evolution, Inc. Aβ BINDING MOLECULES
PE20050627A1 (es) 2003-05-30 2005-08-10 Wyeth Corp Anticuerpos humanizados que reconocen el peptido beta amiloideo
TW200636066A (en) * 2004-12-15 2006-10-16 Elan Pharm Inc Humanized antibodies that recognize beta amyloid peptide
PE20061401A1 (es) * 2004-12-15 2006-12-23 Neuralab Ltd ANTICUERPOS Aß PARA MEJORAR LA COGNICION
WO2006066089A1 (en) * 2004-12-15 2006-06-22 Neuralab Limited Humanized amyloid beta antibodies for use in improving cognition
US8784810B2 (en) * 2006-04-18 2014-07-22 Janssen Alzheimer Immunotherapy Treatment of amyloidogenic diseases
LT2842967T (lt) * 2007-01-18 2017-02-27 Eli Lilly And Company Beta amiloido pegilintas fab
US8003097B2 (en) * 2007-04-18 2011-08-23 Janssen Alzheimer Immunotherapy Treatment of cerebral amyloid angiopathy
BRPI0810118A8 (pt) * 2007-04-18 2015-09-29 Janssen Alzheimer Immunotherap Método para tratar doença, método para efetuar profilaxia contra caa, uso de um agente, método para reduzir amilóide vascular em um paciente, e, kit para tratamento
PL2182983T3 (pl) 2007-07-27 2014-10-31 Janssen Alzheimer Immunotherap Leczenie chorób amyloidowych z wykorzystaniem humanizowanych przeciwciał specyficznych względem Abeta
JO3076B1 (ar) * 2007-10-17 2017-03-15 Janssen Alzheimer Immunotherap نظم العلاج المناعي المعتمد على حالة apoe
US9067981B1 (en) 2008-10-30 2015-06-30 Janssen Sciences Ireland Uc Hybrid amyloid-beta antibodies
US9597379B1 (en) 2010-02-09 2017-03-21 David Gordon Bermudes Protease inhibitor combination with therapeutic proteins including antibodies
US8524220B1 (en) 2010-02-09 2013-09-03 David Gordon Bermudes Protease inhibitor: protease sensitivity expression system composition and methods improving the therapeutic activity and specificity of proteins delivered by bacteria
US8771669B1 (en) 2010-02-09 2014-07-08 David Gordon Bermudes Immunization and/or treatment of parasites and infectious agents by live bacteria
US9737592B1 (en) 2014-02-14 2017-08-22 David Gordon Bermudes Topical and orally administered protease inhibitors and bacterial vectors for the treatment of disorders and methods of treatment
US9616114B1 (en) 2014-09-18 2017-04-11 David Gordon Bermudes Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4265233A (en) * 1978-04-12 1981-05-05 Unitika Ltd. Material for wound healing
AU590238B2 (en) * 1984-12-06 1989-11-02 Amgen, Inc. Recombinant methods for production of serine protease inhibitors and dna sequences useful for same
EP0233838A3 (de) * 1986-02-04 1990-01-31 Incyte Pharmaceuticals, Inc. Neuriten stimulierender Faktor und Prozess für seine Herstellung
DE3606265A1 (de) * 1986-02-27 1987-09-03 Roehm Pharma Gmbh Wundauflage auf polysaccharidbasis als traeger therapeutisch wirksamer, nicht-immobilisierter enzyme und mit hoher saugfaehigkeit
US5006252A (en) * 1986-06-03 1991-04-09 Invitron Purified protease nexin
US5112608A (en) * 1987-03-13 1992-05-12 Incyte Pharmaceuticals Use of protease nexin-I to mediate wound healing

Also Published As

Publication number Publication date
ATE119574T1 (de) 1995-03-15
AU625492B2 (en) 1992-07-16
US5278049A (en) 1994-01-11
EP0251505A1 (de) 1988-01-07
CA1339447C (en) 1997-09-09
EP0251505B1 (de) 1995-03-08
US5495001A (en) 1996-02-27
DE3751128D1 (de) 1995-04-13
AU7372687A (en) 1988-01-07
ES2072250T3 (es) 1995-07-16

Similar Documents

Publication Publication Date Title
ATE119574T1 (de) Rekombinante gereinigte protease, nexin.
GR3006427T3 (de)
NO175158C (no) Fremstilling av human livmorsvevplasminogenaktivator med rekombinant-DNA
ATE281470T1 (de) Rekombinanter proteaseinhibitor des alzheimer- amyloid-proteins
ES2061929T3 (es) Nuevas enzimas proteoliticas y su utilizacion en los detergentes.
EP0278696A3 (de) Arg-Serpin-Hemmer von menschlichem Plasminogen-Aktivator, bezeichnet als PAI-2
FI862756A (fi) Fibroektiner.
DK374286A (da) Serinproteaseinhibitorer og fremgangsmaade til isolering af disse
ATE97421T1 (de) Gentechnologisch hergestellter pankreatischer sekretorischer trypsininhibitor und seine varianten.
ATE92935T1 (de) Serinproteaseinhibitoren und isolierungsverfahren dazu.
FI955721A0 (fi) Urokinaasityyppisen plasminogeenin aktivaattorin inhibiittoreiden ilmentämiseksi
ES2063060T3 (es) Benzamida contra enfermedades cognoscitivas.
ES2165352T3 (es) Gen recombinante que codifica el interferon alfa humano y vector de expresion del mismo.
ATE108831T1 (de) Rinder-interleukin-1-alpha.
KR880701777A (ko) 재조합 dna 방법에 의해 제조된 인간의 췌장 분비 트립신 억제제와 그의 제조방법
DK50987A (da) Polypeptid med plasminogenaktivatorvirkning
IT8321281A0 (it) Un vetro-inverso analogo del decapeptide (5-14)dell'angiotensinogeno equino inibitore specifico della renina con elevata resistenza all'idrolisi enzimatica.
DK0589741T3 (da) Anvendelse af en direkte thrombininhibitor til fremstilling af et lægemiddel med thrombolytisk aktivitet
ES2056123T3 (es) Clonacion del gen que codifica la enzima isoamilasa y su empleo en la produccion de dicha enzima.
DE3583752D1 (de) In bacillus-subtilis verwendbare expressionsplasmide.
DE3854195T2 (de) Polypeptid-verbindungen.
Arocha-Pi Studies on the degradation of fibrinogen by proteolytic enzymes from the larvae of Lanomia achelous (Cramer)
DK96888A (da) Rekombinant humant vaevsplasminogen aktivatormateriale

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: INCYTE PHARMACEUTICALS, INC., PALO ALTO, CALIF., U

8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee